Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 3/20 | 0.48 |
| ▸ | HTR1B | P28222 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HTR1D | P28221 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24313749 | 0.91 | LTA4H (0.63) | LTA4H | |
| SCHEMBL2130060 | 0.86 | LSS (0.52) | LTA4HLMNAALDH1A1CHRNB2CHRNB4 | |
| SCHEMBL3589633 | 0.86 | NQO1 (0.50) | LTA4HRECQLMAPT | |
| SCHEMBL497461 | 0.83 | KCNA3 (0.63) | KCNA3LTA4HHTR1BLMNAHTR1D | |
| SCHEMBL12772058 | 0.83 | LTA4H (0.64) | LTA4H | |
| SCHEMBL1607526 | 0.82 | MAOB (0.48) | LMNAALDH1A1 | |
| SCHEMBL9369921 | 0.81 | KCNA3 (0.50) | KCNA3CA4LTA4HHTR1BHTR1D | |
| SCHEMBL23309720 | 0.81 | LTA4H (0.42) | LTA4HALDH1A1MAPT | |
| SCHEMBL9422520 | 0.81 | LTA4H (0.49) | LTA4H | |
| Hydrochloric Acid SCHEMBL10519295 | 0.80 | KCNA3 (0.60) | KCNA3LTA4HHTR1BLMNAHTR1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118290238-A | Preparation method of isorhapontin | 深圳技术大学 | 2024-07-05 | — | — | CN | claimed |
| CN-113620945-A | RET inhibitor, pharmaceutical composition thereof and application thereof in medicines | 广东东阳光药业有限公司 | 2021-11-09 | — | — | CN | claimed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| US-9293711-B2 | Organic semiconductor formulations | POLYERA CORPORATION (US) | 2016-03-22 | — | — | US | claimed |
| EP-1647262-B2 | Anhydrous cosmetic composition comprising electrophilic monomers and acid, and use for cosmetic treatment of hair | OREAL (FR) | 2012-02-08 | — | — | EP | claimed |
| EP-1455738-B1 | USE OF ELECTROPHILIC MONOMERS FOR HAIR TREATMENT | OREAL (FR) | 2010-07-28 | — | — | EP | claimed |
| EP-1647262-B1 | Anhydrous cosmetic composition comprising electrophilic monomers and acid, and use for cosmetic treatment of hair | OREAL (FR) | 2009-08-05 | — | — | EP | claimed |
| CN-101495657-A | Nucleic Acid Amplification Using Reversibly Modified Oligonucleotides | WANLI BI (US) | 2009-07-29 | — | — | CN | claimed |
| US-7357921-B2 | Hair cosmetic formualtion containing an acrylic or vinyl monomer capable of polymerizing by anionic polymerization in the presence of a nucleophilc agent | L'OREAL (FR) | 2008-04-15 | — | — | US | claimed |
| EP-1847252-A2 | Composition comprising a cyanoacrylate monomer, a glucidic compound and a liquid organic solvent and cosmetic treatment methods | L'Oréal (FR) | 2007-10-24 | — | — | EP | claimed |
| EP-1647264-A1 | use for cosmetic treatment of keratinic material of a composition comprising an electrophilic monomer and a non-siloxane polymer, thereby achieving a rigid coating | L'OREAL (FR) | 2006-04-19 | — | — | EP | claimed |
| EP-1647265-A1 | Use for the cosmetic treatment of keratinous material of non sticky compositions based on electrophilic monomeres and non-silicon polymers | L'OREAL (FR) | 2006-04-19 | — | — | EP | claimed |
| EP-1647259-A1 | use for treatment of keratinic materials of compositions comprising electrophilic monomers and agents forming liquid crystals | L'OREAL (FR) | 2006-04-19 | — | — | EP | claimed |
| EP-1647260-A1 | use for cosmetic treatment of keratinic material of a composition comprising an electrophilic monomer and a non-siloxane polymer, thereby achieving a soft coating | L'OREAL (FR) | 2006-04-19 | — | — | EP | claimed |
| US-20060078523-A1 | Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair | L'OREAL S.A. (FR) | 2006-04-13 | — | — | US | claimed |
| US-20060078522-A1 | Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt | L'OREAL S.A. (FR) | 2006-04-13 | — | — | US | claimed |
| CN-1604275-A | Pattern formation method | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2005-04-06 | — | — | CN | claimed |
| EP-1455738-A2 | USE OF ELECTROPHILIC MONOMERS FOR HAIR TREATMENT | L'OREAL (FR) | 2004-09-15 | — | — | EP | claimed |
| US-20030175229-A1 | Electrophilic monomers for treating the hair | L'OREAL (FR) | 2003-09-18 | — | — | US | claimed |
| WO-2003053380-A2 | USE OF ELECTROPHILIC MONOMERS FOR HAIR TREATMENT | L'OREAL (FR) | 2003-07-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030175229-A1 | Electrophilic monomers for treating the hair | NACA, SUCLG1, TYR | KCNA3 2840/4885CA4 1543/4885LTA4H 955/4885 |
| US-20060078523-A1 | Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair | HOGA1, OAT, SUCLG1 | KCNA3 4580/4885CA4 1024/4885LTA4H 2227/4885 |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | KCNA3 2318/4885CA4 43/4885LTA4H 3533/4885 |
| US-20060078522-A1 | Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt | KRT18, DSG1, DSC1 | KCNA3 343/4885CA4 1016/4885LTA4H 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.